When does this change take effect?

This change is effective Apr 1, 2025.

CommercialCoverageMedium impact

05.00.79l, Insulin Pumps and Long-Term Interstitial Continuous Glucose Monitoring Systems

Q: Who is affected by this change?

This affects Independence Blue Cross Endocrinology, Family Medicine, Internal Medicine, Pediatrics providers on Commercial plans.

Independence Blue Cross·Endocrinology, Family Medicine, Internal Medicine +1 more·Medical Policy

Effective date

Apr 1, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

Commercial insurance policy 05.00.79l covering insulin pumps and continuous glucose monitoring systems has been updated with new provisions effective April 1, 2025. This policy change affects billing and coverage criteria for diabetes management devices and related services.

Action Required

Action needed

By April 1, 2025: Billing team must review updated policy 05.00.79l for insulin pumps and continuous glucose monitoring systems at the provided URL. Update billing protocols and prior authorization requirements for diabetes device claims according to the new commercial policy guidelines. Verify coverage criteria changes that may affect claim processing.

Related policy hubs

Independence Blue Cross policies Endocrinology Family Medicine Internal Medicine Pediatrics